Agilus was earlier called SRL Diagnostics, which was rebranded in May this year. Fortis Healthcare on Friday reported a 9% year-on-year (Yo...

US firm Constellation Alpha had earlier agreed to buy the Indian diagnostic chain, but deal fell through.

The banking regulator inspected bank accounts of the borrowers and, in nine instances, detected transfers of funds to related parties of Re...

Tune in for market news, views and cues.

Among sectoral indices, consumer durables, banks and Healthcare were among top gainers.

"Some midcaps are going down because they got reclassified and people had to dispose them."

Here is a list of top stocks that are likely to be in focus in today's trading session.

Take a look at top stocks likely to stay in the spotlight in today's trading session.

Here is a list of top stocks that are likely to be in focus in today's trading session:

The IT major seems to be gradually getting back on track after Vishal Sikka’s sudden exit.

Tightening of margin trading rules by financial institutions ahead of more than 20 IPOs in the coming week too hurt Chinese stocks.

Proposals for listing of AAI and Pawan Hans have been made in the Draft Civil Aviation Policy, released by Civil Aviation Minister Ashok Ga...

In an interview with ET's Khomba Singh, Fortis Healthcare CEO Aditya Vij defends the listed company's decision to buy stakes in companies, ...

'The funding will help Cocoberry enter the Middle East region besides expanding its reach within India.'

Fortis Healthcare (India) today said its board has approved acquisition of 86 per cent stake in Super Religare Laboratories (SRL) to be bas...

Avigo Capital Partners plans to buy 9.27% stake in Super Religare Laboratories (SRL), ahead of the diagnostics chain’s maiden public issue.

McKinsey and Company's investment arm VASCO has picked up stake worth Rs 10.69 crore in Shivinder Mohan Singh-promoted Fortis Healthcare.